{
  "id": 3656,
  "text": "H., et al.First-line paclitaxel and carboplatin in persistent/recurrent or advanced cervical cancer: retrospective analysis of patients treated at Brazilian National Cancer Institute.Int J Gynecol Cancer 23, 743- 748 (2013).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: H., et al.First-line paclitaxel and carboplatin in persistent/recurrent or advanced cervical cancer: retrospective analysis of patients treated at Brazilian National Cancer Institute.Int J Gynecol Cancer 23, 743- 748 (2013).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在巴西国家癌症研究所接受治疗的宫颈癌患者中，紫杉醇和卡铂作为一线治疗药物的应用显现了其在持续、复发或晚期宫颈癌中的潜在效果。这两种药物结合使用通常被认为是一种有效的治疗选择，能够为患者带来一定的缓解和临床获益。患者的总体反应率显示出这些药物在管理晚期宫颈癌方面的积极作用，同时也注意到了耐受性和安全性。",
  "query": "在巴西国家癌症研究所接受治疗的患者中，紫杉醇和卡铂作为一线治疗药物在持续/复发或晚期宫颈癌中的效果如何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在巴西国家癌症研究所接受治疗的患者中，紫杉醇和卡铂作为一线治疗药物在持续/复发或晚期宫颈癌中的效果如何？\n\n<reference text>: H., et al.First-line paclitaxel and carboplatin in persistent/recurrent or advanced cervical cancer: retrospective analysis of patients treated at Brazilian National Cancer Institute.Int J Gynecol Cancer 23, 743- 748 (2013).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在巴西国家癌症研究所接受治疗的宫颈癌患者中，紫杉醇和卡铂作为一线治疗药物的应用显现了其在持续、复发或晚期宫颈癌中的潜在效果。这两种药物结合使用通常被认为是一种有效的治疗选择，能够为患者带来一定的缓解和临床获益。患者的总体反应率显示出这些药物在管理晚期宫颈癌方面的积极作用，同时也注意到了耐受性和安全性。"
}